Clinical trial
A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers
NCT00411814 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00411814 |
|---|---|
| Title | A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers |
| Official title | A Dose-escalating Study of the Safety and Pharmacokinetics of GSK679586A in Healthy Volunteers and Mild Asthmatics. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GSK679586, Placebo |
| Enrollment | 56 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Dec 15, 2006 |
| Last update posted | Mar 19, 2012 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: